Retirement Systems Of Alabama Vertex Pharmaceuticals Inc Transaction History

Retirement Systems Of Alabama

$25.6 Billion
Q2 2024

A detailed history of Retirement Systems Of Alabama transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Retirement Systems Of Alabama holds 239,221 shares of VRTX stock, worth $111 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

239,221

Previous 250,073 4.34%

Holding current value

$111 Million

Previous $105 Million 7.26%

% of portfolio

0.44%

Previous 0.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$392.81 - $485.53 $4.26 Million - $5.27 Million	-10,852 Reduced 4.34%	239,221 $112 Million
Q1 2024 Apr 30, 2024	BUY	$407.69 - $446.08 $35,061 - $38,362	86 Added 0.03%	250,073 $105 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $5.36 Million - $6.42 Million	15,630 Added 6.67%	249,987 $102 Million
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $60,534 - $64,880	-179 Reduced 0.08%	234,357 $81.5 Million
Q2 2023 Jul 31, 2023	SELL	$314.42 - $351.91 $5.49 Million - $6.14 Million	-17,454 Reduced 6.93%	234,536 $82.5 Million
Q1 2023 May 01, 2023	SELL	$283.23 - $323.1 $12.1 Million - $13.8 Million	-42,844 Reduced 14.53%	251,990 $79.4 Million
Q4 2022 Feb 06, 2023	SELL	$285.76 - $321.48 $842,706 - $948,044	-2,949 Reduced 0.99%	294,834 $85.1 Million
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $25.6 Million - $28.6 Million	-93,575 Reduced 23.91%	297,783 $86.2 Million
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $7.21 Million - $8.97 Million	-30,673 Reduced 7.27%	391,358 $110 Million
Q1 2022 Apr 20, 2022	SELL	$221.42 - $260.97 $2.49 Million - $2.94 Million	-11,264 Reduced 2.6%	422,031 $110 Million
Q4 2021 Jan 20, 2022	SELL	$177.01 - $223.45 $313,661 - $395,953	-1,772 Reduced 0.41%	433,295 $95.2 Million
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $198,622 - $222,274	1,095 Added 0.25%	435,067 $78.9 Million
Q2 2021 Jul 21, 2021	BUY	$187.49 - $221.1 $15.6 Million - $18.4 Million	83,265 Added 23.74%	433,972 $87.5 Million
Q1 2021 Apr 15, 2021	BUY	$207.02 - $241.31 $44.5 Million - $51.9 Million	215,121 Added 158.66%	350,707 $75.4 Million
Q4 2020 Jan 26, 2021	BUY	$207.01 - $276.09 $1.38 Million - $1.84 Million	6,656 Added 5.16%	135,586 $32 Million
Q3 2020 Oct 20, 2020	SELL	$255.65 - $303.1 $360,722 - $427,674	-1,411 Reduced 1.08%	128,930 $35.1 Million
Q2 2020 Jul 23, 2020	SELL	$225.48 - $295.8 $2.06 Million - $2.7 Million	-9,141 Reduced 6.55%	130,341 $37.8 Million
Q1 2020 Apr 20, 2020	SELL	$199.77 - $247.81 $795,284 - $986,531	-3,981 Reduced 2.77%	139,482 $33.2 Million
Q4 2019 Jan 28, 2020	SELL	$166.71 - $223.91 $226,392 - $304,069	-1,358 Reduced 0.94%	143,463 $31.4 Million
Q3 2019 Oct 30, 2019	SELL	$166.23 - $187.09 $1.59 Million - $1.79 Million	-9,560 Reduced 6.19%	144,821 $24.5 Million
Q2 2019 Jul 09, 2019	BUY	$164.61 - $190.37 $649,386 - $751,009	3,945 Added 2.62%	154,381 $28.3 Million
Q1 2019 Apr 15, 2019	SELL	$163.73 - $194.7 $190,254 - $226,241	-1,162 Reduced 0.77%	150,436 $27.7 Million
Q4 2018 Jan 10, 2019	BUY	$151.91 - $192.21 $17,469 - $22,104	115 Added 0.08%	151,598 $25.1 Million
Q3 2018 Oct 24, 2018	SELL	$167.73 - $192.74 $837,140 - $961,965	-4,991 Reduced 3.19%	151,483 $29.2 Million
Q2 2018 Jul 17, 2018	SELL	$145.72 - $169.96 $117,304 - $136,817	-805 Reduced 0.51%	156,474 $26.6 Million
Q1 2018 Apr 27, 2018	SELL	$151.6 - $177.13 $74,890 - $87,502	-494 Reduced 0.31%	157,279 $25.6 Million
Q4 2017 Feb 08, 2018	BUY	$137.28 - $155.55 $368,322 - $417,340	2,683 Added 1.73%	157,773 $23.6 Million
Q3 2017 Nov 06, 2017	BUY	$148.13 - $162.24 $23 Million - $25.2 Million	155,090	155,090 $23.6 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Account

Retirement Systems Of Alabama Vertex Pharmaceuticals Inc Transaction History